Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2026-01-25 @ 10:28 AM
Study NCT ID:
NCT00002866
Status:
COMPLETED
Last Update Posted:
2020-04-01
First Post:
1999-11-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
Sponsor:
NCIC Clinical Trials Group
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
MA15
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None